Evidence map›Paper›PMID 32694788›Full record

ArticleNature metabolism2020

Catecholamines suppress fatty acid re-esterification and increase oxidation in white adipocytes via STAT3.

Shannon M Reilly, Chao-Wei Hung, Maryam Ahmadian, Peng Zhao, Omer Keinan, Andrew V Gomez, Julia H DeLuca, Benyamin Dadpey, Donald Lu, Jessica Zaid and 8 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Targeting the TOPK-STAT3 pathway in keratinocytes and mast cells mediates the therapeutic attenuation of Atopic dermatitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Shannon M ReillyDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. shreilly@ucsd.edu.ORCID http://orcid.org/0000-0003-0412-2446
Chao-Wei HungDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Maryam AhmadianDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Peng ZhaoDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4924-0086
Omer KeinanDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Andrew V GomezDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6408-9097
Julia H DeLucaDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Benyamin DadpeyDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Donald LuDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
Jessica ZaidDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
BreAnne PoirierLife Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
Xiaoling PengLife Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
Ruth T YuGene Expression Laboratory, Salk Institute for Biological Sciences, La Jolla, CA, USA.
Michael DownesGene Expression Laboratory, Salk Institute for Biological Sciences, La Jolla, CA, USA.
Christopher LiddleGene Expression Laboratory, Salk Institute for Biological Sciences, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3936-6790
Ronald M EvansGene Expression Laboratory, Salk Institute for Biological Sciences, La Jolla, CA, USA.
Anne N MurphyDepartment of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-5222-9902
Alan R SaltielDivision of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. asaltiel@ucsd.edu.ORCID http://orcid.org/0000-0002-9726-9828
University of California San Diego · USSalk Institute for Biological Studies · USUniversity of Michigan · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
IVEM and Image Analysis ResourceP41GM103412 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2012 to 2019
$17.9M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
The Role of the Exocyst Complex in Insulin Regulated Glucose TransportR01DK076906 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SALTIEL, ALAN R. · 2007 to 2019
$4.6M
Regulation of Glycogen in Health and DiseaseR01DK117551 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALAN R. SALTIEL · 2018 to 2026
$3.8M
Targeting the mitochondrial pyruvate carrier to treat neurodegenerative diseaseR01NS087611 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, GEOFFREY A, MURPHY, ANNE N. · 2014 to 2018
$2.9M
Protective effects of amlexanox against atherosclerosisR00HL143277 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHAO, PENG · 2021 to 2023
$747k
Il-6 and metabolic crosstalk between tissuesK01DK105075 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI REILLY, SHANNON MARIE · 2015 to 2017
$488k
Protective Effects of Amlexanox Against AtherosclerosisK99HL143277 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHAO, PENG · 2018 to 2019
$314k
An Il-6/Stat3 Autocrine Axis in Adipose TissueR03DK118195 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI REILLY, SHANNON MARIE · 2018 to 2019
$233k
NCI NIH HHS P30 CA023100NHLBI NIH HHS K99 HL143277NHLBI NIH HHS R00 HL143277NIDDK NIH HHS K01 DK105075NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK076906NIDDK NIH HHS R01 DK117551NIDDK NIH HHS R03 DK118195NIGMS NIH HHS P41 GM103412NINDS NIH HHS P30 NS047101NINDS NIH HHS R01 NS087611
6 · The paper itself

Abstract

Catecholamines stimulate the mobilization of stored triglycerides in adipocytes to provide fatty acids (FAs) for other tissues. However, a large proportion is taken back up and either oxidized or re-esterified. What controls the disposition of these FAs in adipocytes remains unknown. Here, we report that catecholamines redirect FAs for oxidation through the phosphorylation of signal transducer and activator of transcription 3 (STAT3). Adipocyte STAT3 is phosphorylated upon activation of β-adrenergic receptors, and in turn suppresses FA re-esterification to promote FA oxidation. Adipocyte-specific Stat3 KO mice exhibit normal rates of lipolysis, but exhibit defective lipolysis-driven oxidative metabolism, resulting in reduced energy expenditure and increased adiposity when they are on a high-fat diet. This previously unappreciated, non-genomic role of STAT3 explains how sympathetic activation can increase both lipolysis and FA oxidation in adipocytes, revealing a new regulatory axis in metabolism.

Indexed as

Adipocytes, WhiteAdrenergic beta-AgonistsAnimalsCatecholaminesDiet, High-FatEnergy MetabolismEstersFatty Acids, NonesterifiedLipolysisMiceMice, Inbred C57BLMice, KnockoutObesityOxidation-ReductionPhosphorylationSTAT3 Transcription FactorAdrenergic beta-AgonistsCatecholaminesEstersFatty Acids, NonesterifiedStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID32694788
PMCPMC7384260
OpenAlexW3033904991

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.